MDPI and ACS Style
Ferrero, J.-M.; Mahammedi, H.; Gravis, G.; Roubaud, G.; Beuzeboc, P.; Largillier, R.; Borchiellini, D.; Linassier, C.; Ebran, N.; Pace-Loscos, T.;
et al. Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics 2023, 15, 651.
https://doi.org/10.3390/pharmaceutics15020651
AMA Style
Ferrero J-M, Mahammedi H, Gravis G, Roubaud G, Beuzeboc P, Largillier R, Borchiellini D, Linassier C, Ebran N, Pace-Loscos T,
et al. Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics. 2023; 15(2):651.
https://doi.org/10.3390/pharmaceutics15020651
Chicago/Turabian Style
Ferrero, Jean-Marc, Hakim Mahammedi, Gwenaelle Gravis, Guilhem Roubaud, Philippe Beuzeboc, Remi Largillier, Delphine Borchiellini, Claude Linassier, Nathalie Ebran, Tanguy Pace-Loscos,
and et al. 2023. "Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer" Pharmaceutics 15, no. 2: 651.
https://doi.org/10.3390/pharmaceutics15020651